An isothermal in vitro DNA amplification method was developed based upon the following sequence of reaction events. Restriction enzyme cleavage and subsequent heat denaturation of a DNA sample generates two singlestranded target DNA fragments (T, and T2). Present in excess are two DNA amplification primers (P1 and P2). The 3' end of PI binds to the 3' end of T,, forming a duplex with 5' overhangs.
displaces the downstream strand that is functionally equivalent to T2. Likewise, extension at the nick on P2-T2 results in displacement of a downstream strand functionally equivalent to Tp. Nicking and polymerization/displacement steps cycle continuously on PI-T, and P2-T2 because extension at a nick regenerates a nickable HincH recognition site. Target amplification is exponential because strands displaced from PI-T, serve as targets for P2 and strands displaced from P2T2 serve as targets for P1. A 106-fold amplification of a genomic sequence from Mycobacterium tuberculosis or Mycobacterium bovis was achieved in 4 h at 37C.
A variety of in vitro nucleic acid amplification techniques are being developed for clinical diagnosis of infectious and genetic diseases. Amplification techniques can be grouped into those requiring temperature cycling [PCR (1) , ligase chain reaction (2-4), and transcription-based amplification (5)] and isothermal systems [self-sustained sequence replication (6) and a Qf3 replicase system (7) ] [for a comparative review, see Kwoh and Kwoh (8) ]. Strand displacement amplification (SDA) is a DNA amplification technique that uses readily available enzymes and does not require temperature cycling. The technique is based upon the ability of a restriction enzyme to nick the unmodified strand of a hemimodified DNA recognition site, and the ability of a 5'-3' exonucleasedeficient DNA polymerase to extend the 3' end at the nick and displace the downstream strand. Exponential target DNA amplification is achieved by coupling sense and antisense reactions in which strands displaced from a sense reaction serve as target for an antisense reaction and vice versa. Tuberculosis is one of the most common human infectious diseases, infecting an estimated one billion worldwide with =.16 million active cases and 3 million deaths per year (9) . Recently, it has received renewed attention due in part to its high incidence among AIDS patients. The disease is caused by Mycobacterium tuberculosis and Mycobacterium bovis. Culture-based diagnosis provides exquisite sensitivity and specificity but requires 3-6 weeks due to the slow growth rate of most pathogenic species of mycobacteria. Acid-fast organisms can be quickly identified in stained smears but with low sensitivity (>104 organisms per ml). Consequently, there is an acute need for a rapid and sensitive test.
The PCR meets these diagnostic requirements and has been applied to mycobacterial infections (10) . An IS6110 insertion element, which is specific for M. tuberculosis and M. bovis, provides an effective target sequence for amplification and detection (11) . SDA was applied to genomic DNA samples from M. tuberculosis and M. bovis using a portion of the IS6110 element as target sequence. We have achieved a 106-fold amplification, thereby establishing SDA as an isothermal alternative for amplifying specific DNA sequences. *To whom reprint requests should be addressed.
MATERIALS AND METHODS
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. The SDA reactions shown in Fig. 3 were terminated after unit/,a) and incubation for 15 min at 37°C. The extension reaction was terminated by heating 10 min at 65°C followed by addition of 2.6 ,ug of native calf thymus DNA (Boehringer Mannheim) and 0.1 vol of 3 M sodium acetate. The DNA was precipitated with 3 vol of ethanol for 10 min at room temperature and recovered by centrifugation for 15 min in a bench-top microcentrifuge. DNA pellets were dissolved in 50%o (wt/vol) urea/20 mM Na2EDTA/0.5 x TBE (16)/0.05% bromophenol blue/xylene cylanol and heated 2 min at 95°C. The SDA reaction products shown in Fig. 4 were detected as follows. Samples (10 ,ul) from a 100-Al SDA reaction mixture were removed at indicated times and the reaction was terminated by heating 2 min at 95°C. The 32P-labeled probe/kinase mixture (2 p.l) was added to each 10-pl sample, and the mixture was heated 2 min at 95°C and then 2 min at 37°C. The 32P-labeled detector probe was extended to a diagnostic length upon addition of 2 ,ul of the Klenow polymerase (1 unit/,ul) and incubation for 15 min at 37°C. The extension reaction was terminated upon addition of 14 p.l of 50%o urea/20 mM Na2EDTA/0.5 x TBE/0.05% bromophenol blue/xylene cylanol. Samples were analyzed by denaturing electrophoresis in a 10% (wt/vol) polyacrylamide gel [acrylamide:N,N'-methyleneacrylamide (18:1)] containing 50% urea and 0.5x TBE. 32P-labeled gel electrophoresis bands were excised and radioactivity was quantified by liquid scintillation counting.
RESULTS AND DISCUSSION
SDA Design. The fundamental reaction scheme of SDA is depicted in Fig. 1 . A single-stranded target DNA fragment and a DNA amplification primer bind at their complementary
| polymerize using dCTP, dGTP, TTP and dATPaS. (Fig. 1) . In contrast, amplification using two primers proceeds exponentially because strands displaced from the Pj T1 complex serve as target for primer P2
and strands displaced from the P2-T2 complex serve as target for primer P1 (Fig. 2) . (17) have identified many restriction enzymes that nick hemiphosphorothioate recognition sites. Only a small subset of these restriction enzymes function in SDA because of the special requirement that the polymerization/displacement step must regenerate a nickable recognition site. Phosphorothioate linkages incorporated into the primer strand must not inhibit subsequent nicking. Suitable restriction enzymes identified to date satisfy this requirement through nonpalindromic recognition sites. In addition to HincII used in the present study, HindII, Ava I, Nci I, and Fnu4HI also function in SDA (G.T.W., M.C.L., and J.G.N., unpublished results).
To function adequately in SDA, a restriction enzyme must efficiently nick one strand of a hemiphosphorothioate recognition site and quickly dissociate from the nicked site to allow the DNA polymerase access. Many restriction enzymes efficiently nick a nonpalindromic hemiphosphorothioate recognition site but apparently dissociate too slowly from the nicked site for efficient operation in SDA (M.C.L., unpublished results).
Clearly, it is essential that the target DNA sequence does not contain a recognition sequence for the restriction enzyme used in SDA (HincII in the present investigation).
To function in SDA, a DNA polymerase must (i) initiate polymerization at a nick, (ii) utilize dNTP[aS]s, and (iii) displace a downstream strand (and lack 5'-3' exonuclease activity). In addition to the exo-Klenow polymerase used in the present study, the Klenow polymerase (sequencing grade, Boehringer Mannheim) and the large fragment of Bacillus stearothermophilus (Bio-Rad) also function in SDA (G.T.W. and M.C.L., unpublished results).
SDA Primer Design. Each SDA primer contains a target binding region at its 3' end. A recognition site for the nicking restriction enzyme is located 5' to the target binding region. The recognition sequence is flanked on the 5' side by a stretch of DNA typically -20 nucleotides long, the sequence of which is not critical. The 5' end of a primer provides flanking DNA to facilitate binding ofthe nicking restriction enzyme to the recognition site. The 5' end also must be long enough to provide a stable polymerase priming site after nicking by the restriction enzyme. The SDA primers in the current investigation are partially complementary at their 5' ends. This was designed to reduce nonspecific binding. However, 5' complementarity between primers is not essential for SDA.
SDA primers undoubtedly bind nonspecifically at 370C to nontarget DNA present in the sample (human placental DNA in the current investigation). However, SDA not only requires that primers bind to DNA fragments with adequate homology but also requires an appropriately positioned 3' end on the target strand to form a hemiphosphorothioate recognition site for the nicking restriction enzyme. Use of a 3'-5' exonuclease-deficient DNA polymerase enhances primer specificity in SDA because such a DNA polymerase is less likely to extend nonspecific complexes containing mismatched 3' ends.
In the PCR, primers can bind nonspecifically to one another, resulting in amplification of what are commonly referred to as primer dimers. These background amplification reactions can effectively attenuate target-specific amplification by competing for PCR reagents. Nonspecific binding between SDA primers can also result in amplification of primer dimers. Consequently, the terminal 3' nucleotides of each SDA primer are chosen to minimize formation of primer dimers that can be extended by DNA polymerase. Again, use of a 3'-5' exonuclease-deficient DNA polymerase reduces extension of primer dimers with mismatched 3' ends. Extension of nonspecific complexes can be further reduced by using SDA primers whose 3'-hydroxyl groups are modified to prevent extension by DNA polymerase. It is not essential Proc. Natl. Acad Sci. USA 89 (1992) Proc. Natl. Acad. Sci. USA 89 (1992) 395 that an SDA primer be extended upon binding to a target fragment. The hemiphosphorothioate recognition site is still formed through extension ofthe 3' end ofthe target fragment. Primers with modified 3'-hydroxyl groups also allow use of DNA polymerases possessing 3'-5' exonuclease activity (e.g., the Klenow polymerase) by ensuring excess singlestranded primers are not degraded during SDA.
SDA of Genomic DNA from M. tuberculosis and M. bovis. Rsa I cleavage of genomic DNA from either M. tuberculosis or M. bovis produced a 47-bp target fragment for SDA. A set of samples containing various amounts of the target DNA fragment and 0.1 ug of Rsa I-cleaved human placental DNA was subjected to SDA using the exo-Klenow polymerase and HincII. Amplified target fragments were detected by DNA polymerase extension of a 32P-labeled probe that is complementary to an internal segment ofthe target sequence. NI' bovis copies of M. bovis due to the limiting amount of the 32p_ labeled detector probe. Reactions performed without addition of target DNA exhibit faint SDA-specific 32P-labeled bands in Fig. 3 due to accidental contamination of reagents with '-10 target molecules (=1 M. tuberculosis or -10 M. bovis genome copies). It is extremely difficult to maintain reagents that are free of target DNA contaminants on the scale of 10 molecules. Contamination control is a common problem with the PCR as well (19) .
A recombinant plasmid containing a single copy of the IS6110 sequence served as a standard for estimating the degree of amplification in SDA reactions. (The plasmid was used as a standard because it was available in sufficient quantity.) Comparison of amplified samples with standards allows us to estimate an amplification factor of 106-fold. A constant amplification factor is observed for each sample, regardless of the initial amount of target.
The current method of detection using a 32P-labeled probe allows detection of as few as -108 DNA molecules. This sensitivity in conjunction with 106-fold amplification allows clear detection of as few as 10 genome copies of M. tuberculosis and 100 genome copies of M. bovis using the 47-bp Rsa I fragment from the insertion element IS6110 as target.
We have not yet examined the replication fidelity of the exo Klenow polymerase during SDA. Detection using a target-sequence-specific 32P-labeled probe indicates fidelity is sufficient for diagnostic applications. However, fidelity may be a concern in other applications. Only a few pertinent investigations are published. The exo-Klenow polymerase is 4-to 7-fold less accurate than the Klenow polymerase (20) . E. coli DNA polymerase I exhibits a 20-fold decrease in fidelity when dCTP is replaced with dCTP[aS] (21) . This decrease in fidelity was attributed to inhibition of the 3'-5' exonuclease proofreading activity of DNA polymerase I by dCTP [aS] . The net result of each cycle is a doubling of product number (P) and consumption of reagents (R):
If reagents are not replenished during the course of the reaction, the level of product at time t is given by: Pt = (ROQek')/(j + Qek) [1] where Q = Po/(Ro -PO), PO is the initial product (target) concentration, and Ro is initial concentration of limiting reagent. The apparent rate constant k is related to the cycling time r by k = (In 2)/r.
An SDA reaction should proceed exponentially until the concentration of some reagent R becomes limiting. Product concentration is expected to increase exponentially until it reaches a level -5-fold less than RO. The exponential phase is then followed by a much less efficient amplification phase as the product concentration approaches RO. The final product concentration should be independent of the initial target concentration. t Time courses of experimental SDA reactions are shown in Fig. 4B . Each experimental SDA reaction exhibits exponential amplification over the first 60 min. By the 2-h mark, each reaction has switched from exponential amplification to a much less efficient amplification phase, during which product concentration asymptotically approaches a level that depends on the initial amount of target. In each reaction, the number of target molecules is amplified by a constant amount (_106-fold after 5 h), regardless of the number of initial targets. This results in a dose-response relationship between initial and final target levels, in sharp contrast to the results predicted by the theoretical curves in Fig. 4A . A similar dose-response relationship was reported for another amplification technique referred to as self-sustained sequence replication (6) .
In SDA reactions, addition of fresh enzymes at the 1-h mark does not prolong the exponential phase, indicating enzyme degradation is not responsible for the reduction in amplification efficiency after that point. The observed dosetFig. 4A is intended to be a qualitative illustration of the reaction kinetics expected for SDA. Eq. 1 is quantitatively correct only if reagent R is consumed in the rate-determining reaction step. ( We have yet to establish the contribution of individual steps to the overall reaction rate.) If response relationship probably results from amplification of nontarget DNA (human placental DNA) that is present in large excess over specific target sequences. Although the intrinsic efficiency of this background amplification is expected to be very low, the high level of nontarget DNA may lead to significant accumulation ofundesired products. These background reactions should not interfere with target amplification early in the reaction when reagents are present in excess. However, the exponential amplification phase (during which the number of target sequences doubles every 5.3 min) can only be sustained while the concentration of limiting reagent R remains at least 5-to 10-fold higher than amplified product levels (see Eq. 1 and Fig. 4A ). Competing background reactions will prematurely deplete reagent levels and as a consequence will shorten the period during which exponential amplification of target sequences can occur. In addition, competing reactions will limit the final quantity of amplified target sequences that can be produced because reagents converted to background products will be unavailable for the production of target sequences. Consequently, a dose-response relationship will result because the degree to which target amplification can compete against background reactions will depend on the ratio of target to nontarget sequences present at the beginning of the reaction.
